PNSP 7-2026 Acquisition of Active Pharmaceutical Ingredients Interferon Beta 1A, Nusinersen, Natalizumab, Diroximel and Fumarate (Biogen Spain, S.L.U.) for the GAI of Guadalajara
About This Opportunity
Gerencia del Area de Atención Integrada de Guadalajara | 1,298,876.95 EUR
This is a services contract in the health and medical services and governance and public administration sectors. Located in Spain, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 1.3 million.
Published through PLACSP - Plataforma de Contratación del Sector Público, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for services in the health and medical services sector. Service contracts are typically evaluated on both technical quality and price, and may require bidders to demonstrate relevant experience and qualified personnel. This contract has already been awarded. The information is published for transparency and market intelligence purposes.
Description
Original language: SpanishId licitación: 2026/000915; Órgano de Contratación: Gerencia del Area de Atención Integrada de Guadalajara; Importe: 1298876.95 EUR; Estado: ADJ
Data provenance
This notice is sourced from PLACSP - Plataforma de Contratación del Sector Público and was originally published on May 11, 2026. Last refreshed today. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.
About Gerencia del Area de Atención Integrada de Guadalajara
Gerencia del Area de Atención Integrada de Guadalajara has issued 18 procurement notices on BidsFactory, including 2 currently open and 14 awarded contracts. Activity concentrates in Governance & Public Administration, Health & Medical, and Education & Training. All notices are published for Spain. Notices are distributed via PLACSP - Plataforma de Contratación del Sector Público. Most recent publication: May 19, 2026.
Frequently asked questions about this tender
What type of contract is this?
This is a Services contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.
How much was the contract awarded for?
BIOGEN SPAIN, S.L.U. was awarded the contract for €1,277,795. The figure reflects the value disclosed by the contracting authority in the award notice.
Where will the contract be performed?
The contract is for delivery in Spain. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.
How can I submit a bid?
Visit PLACSP - Plataforma de Contratación del Sector Público to access the full notice, required documents, and submission instructions provided by the contracting authority.
Is this tender still open?
No — the contract has already been awarded to BIOGEN SPAIN, S.L.U.. The award notice is archived on BidsFactory for transparency and market intelligence.
Who is the contracting authority?
This notice was issued by Gerencia del Area de Atención Integrada de Guadalajara in Spain. The authority is responsible for evaluating bids, awarding the contract, and managing performance.
Find tenders like this automatically
Set up alerts and filters that match your business — never miss a relevant opportunity again.